@article{b5c434e5b9174a9ebe1ce6ed7fe815e4,
title = "PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells",
keywords = "Animals, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Bridged Bicyclo Compounds, Heterocyclic/administration \& dosage, Cell Line, Tumor, Cerebellar Neoplasms/drug therapy, Cisplatin/administration \& dosage, Drug Resistance, Neoplasm, Drug Synergism, Humans, Medulloblastoma/drug therapy, Mice, Mice, SCID, Piperazines/administration \& dosage, Protein Phosphatase 2/antagonists \& inhibitors, Xenograft Model Antitumor Assays",
author = "Ho, \{Winson S.\} and Feldman, \{Michael J.\} and Dragan Maric and Lauren Amable and Hall, \{Matthew D.\} and Feldman, \{Gerald M.\} and Abhik Ray-Chaudhury and Lizak, \{Martin J.\} and Vera, \{Juan Carlos\} and \{Aaron Robison\}, R. and Zhengping Zhuang and Heiss, \{John D.\}",
year = "2016",
month = mar,
day = "15",
doi = "10.18632/oncotarget.6970",
language = "English",
volume = "7",
pages = "12447--12463",
journal = "Oncotarget",
issn = "1949-2553",
number = "11",
}